TAHO Pharma Takes a Bold Step with New Anticoagulant Film Submission to FDA TAHO Pharma has submitted a New Drug Application for TAH3311, an innovative Apixaban Oral Dissolving Film, to the U.S. FDA. This product aims to enhance anticoagulant therapy significantly.

TAHO Pharma Takes a Bold Step with New Anticoagulant Film Submission to FDA #Taiwan #Taipei #TAH3311 #Apixaban #TAHO_Pharma

TAHO Pharmaceuticals Announces Positive Results for Innovative Oral Anticoagulant TAH3311 TAHO Pharmaceuticals has revealed promising early results from their pivotal study on TAH3311, the world's first oral dissolving film anticoagulant, showing effectiveness similar to traditional tablets.

TAHO Pharmaceuticals Announces Positive Results for Innovative Oral Anticoagulant TAH3311 #Taipei #USA #TAHO_Pharmaceuticals #TAH3311 #Apixaban

TAHO Pharmaceuticals Announces Positive Results for TAH3311, a Breakthrough Oral Dissolving Film Anticoagulant TAHO Pharmaceuticals has reported positive preliminary results from the pivotal study of TAH3311, the world's first oral dissolving film anticoagulant, marking a significant advancement in stroke treatment.

TAHO Pharmaceuticals Announces Positive Results for TAH3311, a Breakthrough Oral Dissolving Film Anticoagulant #Taipei #USA #TAHO_Pharmaceuticals #TAH3311 #Apixaban

TAHO Pharmaceuticals Announces Promising Results for First Oral Anticoagulant ODF TAH3311 TAHO Pharmaceuticals reveals strong preliminary findings from the pivotal study for TAH3311, the world's first oral dissolving film anticoagulant, set to improve patient care.

TAHO Pharmaceuticals Announces Promising Results for First Oral Anticoagulant ODF TAH3311 #Taiwan #Taipei #TAHO_Pharmaceuticals #TAH3311 #Apixaban

TAHO Pharmaceuticals Successfully Concludes Pivotal Trial of Innovative Oral Dissolving Anticoagulant TAHO Pharmaceuticals announces the successful completion of its pivotal trial for TAH3311, an innovative oral dissolving film anticoagulant, demonstrating its potential in the market.

TAHO Pharmaceuticals Successfully Concludes Pivotal Trial of Innovative Oral Dissolving Anticoagulant #Taiwan #Taipei #TAHO_Pharmaceuticals #TAH3311 #Apixaban